419 related articles for article (PubMed ID: 32941954)
21. Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study.
Zhang X; Eyck BM; Yang Y; Liu J; Chao YK; Hou MM; Hung TM; Pang Q; Yu ZT; Jiang H; Law S; Wong I; Lam KO; van der Wilk BJ; van der Gaast A; Spaander MCW; Valkema R; Lagarde SM; Wijnhoven BPL; van Lanschot JJB; Li Z
BMC Cancer; 2020 Mar; 20(1):194. PubMed ID: 32143580
[TBL] [Abstract][Full Text] [Related]
22. An artificial neural network-based radiomics model for predicting the radiotherapy response of advanced esophageal squamous cell carcinoma patients: a multicenter study.
Xie Y; Liu Q; Ji C; Sun Y; Zhang S; Hua M; Liu X; Pan S; Hu W; Ma Y; Wang Y; Zhang X
Sci Rep; 2023 May; 13(1):8673. PubMed ID: 37248363
[TBL] [Abstract][Full Text] [Related]
23. A tumor immune microenvironment-related integrated signature can predict the pathological response and prognosis of esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A multicenter study in China.
Wu P; Zhang Z; Yuan Y; Zhang C; Zhang G; Xue L; Yang H; Wang L; Zheng X; Zhang Y; Yuan Y; Lei R; Yang Z; Zheng B; Xue Q; Sun N; He J
Int J Surg; 2022 Nov; 107():106960. PubMed ID: 36257585
[TBL] [Abstract][Full Text] [Related]
24. Ability of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography to Predict Outcomes of Neoadjuvant Chemoradiotherapy Followed by Surgical Treatment for Esophageal Squamous Cell Carcinoma.
Hamai Y; Hihara J; Emi M; Furukawa T; Yamakita I; Kurokawa T; Okada M
Ann Thorac Surg; 2016 Oct; 102(4):1132-9. PubMed ID: 27319990
[TBL] [Abstract][Full Text] [Related]
25. Deep learning radiomics based on contrast enhanced computed tomography predicts microvascular invasion and survival outcome in early stage hepatocellular carcinoma.
Yang Y; Zhou Y; Zhou C; Ma X
Eur J Surg Oncol; 2022 May; 48(5):1068-1077. PubMed ID: 34862094
[TBL] [Abstract][Full Text] [Related]
26. FDG PET using SUV
Huang YC; Lu HI; Huang SC; Hsu CC; Chiu NT; Wang YM; Chiu YC; Li SH
BMC Med Imaging; 2017 Jan; 17(1):1. PubMed ID: 28056868
[TBL] [Abstract][Full Text] [Related]
27. Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers.
Zhu Y; Yao W; Xu BC; Lei YY; Guo QK; Liu LZ; Li HJ; Xu M; Yan J; Chang DD; Feng ST; Zhu ZH
BMC Cancer; 2021 Oct; 21(1):1167. PubMed ID: 34717582
[TBL] [Abstract][Full Text] [Related]
28. CT-based deep learning radiomics and hematological biomarkers in the assessment of pathological complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma: A two-center study.
Zhang M; Lu Y; Sun H; Hou C; Zhou Z; Liu X; Zhou Q; Li Z; Yin Y
Transl Oncol; 2024 Jan; 39():101804. PubMed ID: 37839176
[TBL] [Abstract][Full Text] [Related]
29. Preoperative CT radiomics of esophageal squamous cell carcinoma and lymph node to predict nodal disease with a high diagnostic capability.
Wu YP; Wu L; Ou J; Cao JM; Fu MY; Chen TW; Ouchi E; Hu J
Eur J Radiol; 2024 Jan; 170():111197. PubMed ID: 37992611
[TBL] [Abstract][Full Text] [Related]
30. 3D Deep Learning Model for the Pretreatment Evaluation of Treatment Response in Esophageal Carcinoma: A Prospective Study (ChiCTR2000039279).
Li X; Gao H; Zhu J; Huang Y; Zhu Y; Huang W; Li Z; Sun K; Liu Z; Tian J; Li B
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(4):926-935. PubMed ID: 34229050
[TBL] [Abstract][Full Text] [Related]
31. Radiomics Nomogram with Added Nodal Features Improves Treatment Response Prediction in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Study.
Li K; Zhang S; Hu Y; Cai A; Ao Y; Gong J; Liang M; Yang S; Chen X; Li M; Tian J; Shan H
Ann Surg Oncol; 2023 Dec; 30(13):8231-8243. PubMed ID: 37755566
[TBL] [Abstract][Full Text] [Related]
32. Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.
Yu FH; Miao SM; Li CY; Hang J; Deng J; Ye XH; Liu Y
Eur Radiol; 2023 Aug; 33(8):5634-5644. PubMed ID: 36976336
[TBL] [Abstract][Full Text] [Related]
33. Establishing a survival prediction model for esophageal squamous cell carcinoma based on CT and histopathological images.
Wang J; Wu LL; Zhang Y; Ma G; Lu Y
Phys Med Biol; 2021 Jul; 66(14):. PubMed ID: 34192686
[TBL] [Abstract][Full Text] [Related]
34. Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study.
Borggreve AS; Mook S; Verheij M; Mul VEM; Bergman JJ; Bartels-Rutten A; Ter Beek LC; Beets-Tan RGH; Bennink RJ; van Berge Henegouwen MI; Brosens LAA; Defize IL; van Dieren JM; Dijkstra H; van Hillegersberg R; Hulshof MC; van Laarhoven HWM; Lam MGEH; van Lier ALHMW; Muijs CT; Nagengast WB; Nederveen AJ; Noordzij W; Plukker JTM; van Rossum PSN; Ruurda JP; van Sandick JW; Weusten BLAM; Voncken FEM; Yakar D; Meijer GJ;
BMC Cancer; 2018 Oct; 18(1):1006. PubMed ID: 30342494
[TBL] [Abstract][Full Text] [Related]
35. Contrast-enhanced CT radiomics features to preoperatively identify differences between tumor and proximal tumor-adjacent and tumor-distant tissues of resectable esophageal squamous cell carcinoma.
Gao D; Tan BG; Chen XQ; Zhou C; Ou J; Guo WW; Zhou HY; Li R; Zhang XM; Chen TW
Cancer Imaging; 2024 Jan; 24(1):11. PubMed ID: 38243339
[TBL] [Abstract][Full Text] [Related]
36. Combining the radiomic features and traditional parameters of
Chen YH; Lue KH; Chu SC; Chang BS; Wang LY; Liu DW; Liu SH; Chao YK; Chan SC
Ann Nucl Med; 2019 Sep; 33(9):657-670. PubMed ID: 31218571
[TBL] [Abstract][Full Text] [Related]
37. A prediction model for degree of differentiation for resectable locally advanced esophageal squamous cell carcinoma based on CT images using radiomics and machine-learning.
Kawahara D; Murakami Y; Tani S; Nagata Y
Br J Radiol; 2021 Aug; 94(1124):20210525. PubMed ID: 34235955
[TBL] [Abstract][Full Text] [Related]
38. Computed tomography-based radiomic analysis for prediction of treatment response to salvage chemoradiotherapy for locoregional lymph node recurrence after curative esophagectomy.
Gu L; Liu Y; Guo X; Tian Y; Ye H; Zhou S; Gao F
J Appl Clin Med Phys; 2021 Nov; 22(11):71-79. PubMed ID: 34614265
[TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced CT-based radiomic analysis for determining the response to anti-programmed death-1 therapy in esophageal squamous cell carcinoma patients: A pilot study.
Yang Q; Huang H; Zhang G; Weng N; Ou Z; Sun M; Luo H; Zhou X; Gao Y; Wu X
Thorac Cancer; 2023 Nov; 14(33):3266-3274. PubMed ID: 37743537
[TBL] [Abstract][Full Text] [Related]
40. Analyzing the post-contrast attenuation of the esophageal wall on routine contrast-enhanced MDCT examination can improve the diagnostic accuracy in response evaluation of the squamous cell esophageal carcinoma to neoadjuvant chemoradiotherapy in comparison with the esophageal wall thickness.
Djuric-Stefanovic A; Jankovic A; Saponjski D; Micev M; Stojanovic-Rundic S; Cosic-Micev M; Pesko P
Abdom Radiol (NY); 2019 May; 44(5):1722-1733. PubMed ID: 30758534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
